ES2062024T3 - Nuevo pentapeptido y un procedimiento para su preparacion. - Google Patents

Nuevo pentapeptido y un procedimiento para su preparacion.

Info

Publication number
ES2062024T3
ES2062024T3 ES89309237T ES89309237T ES2062024T3 ES 2062024 T3 ES2062024 T3 ES 2062024T3 ES 89309237 T ES89309237 T ES 89309237T ES 89309237 T ES89309237 T ES 89309237T ES 2062024 T3 ES2062024 T3 ES 2062024T3
Authority
ES
Spain
Prior art keywords
preparation
procedure
pentapeptide
new
new pentapeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89309237T
Other languages
English (en)
Inventor
Jan Erik Paulsen
Karl-Ludvig Reichelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hafslund Nycomed AS
Original Assignee
Hafslund Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed AS filed Critical Hafslund Nycomed AS
Application granted granted Critical
Publication of ES2062024T3 publication Critical patent/ES2062024T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UN NUEVO PENTAPEPTIDO DE FORMULA GENERAL (I), DONDE: Z ES CH2 O CO; Y ES H O OH, Y X1, X2 Y X3 SON CADA UNO INDEPENDIENTEMENTE OH O NH2 DE MANERA QUE X2 Y X3 NO SON NH2. EL PENTAPEPTIDO PUEDE SER USADO COMO COMPONENTE ACTIVO EN COMPOSICIONES. LA PREPARACION DEL MISMO ES DESCRITA.
ES89309237T 1988-09-13 1989-09-12 Nuevo pentapeptido y un procedimiento para su preparacion. Expired - Lifetime ES2062024T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Publications (1)

Publication Number Publication Date
ES2062024T3 true ES2062024T3 (es) 1994-12-16

Family

ID=19891239

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89309237T Expired - Lifetime ES2062024T3 (es) 1988-09-13 1989-09-12 Nuevo pentapeptido y un procedimiento para su preparacion.

Country Status (19)

Country Link
EP (2) EP0434722A1 (es)
JP (1) JPH04501710A (es)
KR (1) KR900701830A (es)
CN (1) CN1041158A (es)
AT (1) ATE102215T1 (es)
AU (1) AU623687B2 (es)
DE (1) DE68913411T2 (es)
DK (1) DK43891A (es)
ES (1) ES2062024T3 (es)
FI (1) FI911219A7 (es)
HU (2) HU206373B (es)
LV (1) LV10289B (es)
MD (1) MD503C2 (es)
MY (1) MY104912A (es)
NO (2) NO884054D0 (es)
NZ (1) NZ230625A (es)
RU (1) RU2010799C1 (es)
WO (1) WO1990002754A1 (es)
ZA (1) ZA896944B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
TW222280B (es) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
CN1070867C (zh) * 1994-08-26 2001-09-12 诺沃挪第克公司 三叶形肽双体
RU2297239C1 (ru) * 2006-05-30 2007-04-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591748A (en) 1949-12-23 1952-04-08 Hercules Powder Co Ltd Amphoteric cellulose derivatives
FR2110268B1 (es) 1970-10-07 1976-06-04 Minnesota Mining & Mfg
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
FI911219A0 (fi) 1991-03-12
NZ230625A (en) 1991-06-25
NO910933L (no) 1991-03-08
KR900701830A (ko) 1990-12-04
NO910933D0 (no) 1991-03-08
HU206373B (en) 1992-10-28
MD503C2 (ro) 1996-07-31
CN1041158A (zh) 1990-04-11
DE68913411T2 (de) 1994-06-23
FI911219A7 (fi) 1991-03-12
NO884054D0 (no) 1988-09-13
LV10289B (en) 1995-04-20
JPH04501710A (ja) 1992-03-26
HU895790D0 (en) 1991-11-28
ATE102215T1 (de) 1994-03-15
MD503B1 (en) 1996-03-29
EP0434722A1 (en) 1991-07-03
MY104912A (en) 1994-06-30
RU2010799C1 (ru) 1994-04-15
DE68913411D1 (de) 1994-04-07
ZA896944B (en) 1990-06-27
EP0360481A1 (en) 1990-03-28
WO1990002754A1 (en) 1990-03-22
DK43891D0 (da) 1991-03-12
AU4224089A (en) 1990-04-02
AU623687B2 (en) 1992-05-21
DK43891A (da) 1991-03-12
HUT58766A (en) 1992-03-30
EP0360481B1 (en) 1994-03-02
LV10289A (lv) 1994-10-20

Similar Documents

Publication Publication Date Title
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ES2061581T3 (es) Un procedimiento para preparar un compuesto cefem.
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
PT720482E (pt) Prosaposina e peptidos derivados da citocina utilizados como agentes
ATE210677T1 (de) Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
PE109698A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ES2151921T3 (es) Analogo de dolastatina.
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
ES2148469T3 (es) N-hidroxipiperidinas como agentes de barrido de radicales superoxido.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
ES2155827T3 (es) 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
DE69011006D1 (de) Antibiotische Mittel.
ATE138651T1 (de) Substituierte n-(chinolin-2-yl- methoxy)benzylsulfonylharnstoffe
ES2062024T3 (es) Nuevo pentapeptido y un procedimiento para su preparacion.
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
DE59106087D1 (de) In Wasser dispergierbare, elektrolytstabile Polyetherester-modifizierte Polyurethanionomere.
ES2057322T3 (es) Derivados de amida de aminoacido substituidos, su fabricacion y uso.
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
ES2054186T3 (es) Composicion antihepatopatica.
GT199900024A (es) Fenilglicinamida n-sulfonilica y n-sulfinilica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 360481

Country of ref document: ES